Glucocorticoids reduce tachykinin NK2 receptor expression in bovine tracheal smooth muscle

European Journal of Pharmacology

Volumn 344, Issue 1, 1998, Pages 99-106

  Katsunuma, Toshio ^a   Mak, Judith C W ^a   Barnes, Peter J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Glucocorticoid; Smooth muscle, airway; Tachykinin NK2 receptor

Indexed keywords

CYCLOHEXIMIDE; DACTINOMYCIN; DEXAMETHASONE; GLUCOCORTICOID; MIFEPRISTONE; NEUROKININ 2 RECEPTOR; SAREDUTANT; TACHYKININ RECEPTOR;

ANIMAL TISSUE; ARTICLE; BRONCHOSPASM; CATTLE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRACHEA MUSCLE;

ANIMALS; CATTLE; CYCLOHEXIMIDE; DEXAMETHASONE; GENE EXPRESSION REGULATION; HUMANS; MUSCLE, SMOOTH; PROTEIN SYNTHESIS INHIBITORS; RECEPTORS, NEUROKININ-2; RNA, MESSENGER; TRACHEA; TRANSCRIPTION, GENETIC;

EID: 0032567915     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01562-8     Document Type: Article

References (40)

1. Abraham W.M., Ahmed A., Cortes A., Soler M., Farmer S.G., Baugh L.E., Harbeson S.L. Airway effects of inhaled bradykinin, substance P, and neurokinin A in sheep. J. Allergy Clin. Immunol. 87:1991;557-564.
2. Advenier C., Naline E., Drapeau G., Regoli D. Relative potencies of neurokinins in guinea pig and human bronchus. Eur. J. Pharmacol. 139:1987;133-137.
3. Bai T.R., Zhou D., Weir T., Walker B., Hegele R., Hayashi S., McKay K., Bondy G.P., Fong T. Substance P (NK1)- and neurokinin A (NK2)-receptor gene expression in inflammatory airway diseases. Am. J. Physiol. 269:1995;L309-L317.
4. Barnes P.J. Neuropeptides and asthma. Am. Rev. Respir. Dis. 143:1991;S28-S32.
5. Barnes P.J. Inhaled glucocorticoids for asthma. N. Engl. J. Med. 332:1995;868-875.
6. Barnes P.J. Is asthma a nervous disease? Chest. 107:1995;119S-125S.
7. Barnes P.J. Molecular mechanisms of steroid action in asthma. J. Allergy Clin. Immunol. 97:1996;159-168.
8. Barnes P.J., Baraniuk J.N., Belvisi M.G. Neuropeptides in the respiratory tract (Part I). Am. Rev. Respir. Dis. 144:1991;1187-1198.
9. Bertrand C., Geppetti P., Graf P.D., Foresi A., Nadel J.A. Involvement of neurologic inflammation in antigen-induced bronchoconstriction in guinea pigs. Am. J. Physiol. 265:1993;L507-L511.
10. Boichot E., Germain N., Lagente V., Advenier C. Prevention by the tachykinin NK2 receptor antagonist, SR 48968, of antigen-induced airway hyperresponsiveness in sensitized guinea-pigs. Br. J. Pharmacol. 114:1995;259-261.
11. Cheung D., Bel E.H., Hartigh J.D., Dijkman J.H., Sterk P.J. The effect of an inhaled neutral endopeptidase inhibitor, thiorphan, on airway responses to neurokinin A in normal humans in vivo. Am. Rev. Respir. Dis. 145:1992;1275-1280.
12. Cheung D., Timmers M.C., Zwinderman A.H., Hartigh J.D., Dijkman J.H., Sterk P.J. Neutral endopeptidase activity and airway hyperresponsiveness to neurokinin A in asthmatic subjects in vivo. Am. Rev. Respir. Dis. 148:1993;1467-1473.
13. Chiba Y., Misawa M. Inhibition of neutral endopeptidase increase airway responsiveness to ACh in nonsensitized normal rats. J. Appl. Physiol. 78:1995;394-402.
14. Chomczynski P., Sacchi N. Single-step of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
15. Crimi N., Oliveri R., Polosa R., Pulvirenti G., Prosperini G., Palemo F., Mistretta A. Effect of oral terfenadine on bronchoconstrictor response to inhaled neurokinin A and histamine in asthmatic subjects. Eur. Respir. J. 6:1993;1462-1467.
16. Crimi N., Palermo F., Oliveri R., Polosa R., Magri S., Mistretta A. Inhibition of neutral endopeptidase potentiates bronchoconstriction induced by neurokinin A in asthmatic patients. Clin. Exp. Allergy. 24:1994;115-120.
17. 3H ]SR 48968, a potent nonpeptide radioligand antagonist of the neurokinin-2 receptor Biochem. Biophys. Res. Commun. 191:1993;1172-1177.
18. Frossard N., Advenier C. Tachykinin receptors and the airways. Life Sci. 49:1991;1941-1953.
19. Girard V., Naline E., Vilain P., Emonds-Alt X., Advenier C. Effect of the two tachykinin antagonists, SR 48968 and SR 140333, on cough induced by citric acid in the unanaesthetized guinea-pig. Eur. Respir. J. 8:1995;1110-1114.
20. Girard V., Yavo J.C., Emonds-Alt X., Advenier C. The tachykinin NK2 receptor antagonist SR 48968 inhibits citric acid-induced airway hyperresponsiveness in guinea pigs. Am. J. Respir. Crit. Care Med. 153:1996;1496-1502.
21. Greenberg, M.E., Bender, T.P., 1992. Identification of newly transcribed RNA. In: Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., Smith, J.A., Struhl, K. (Eds.), Current Protocols in Molecular Biology. Wiley, New York, pp. 4.10.1-4.10.9.
22. Harrison N.K., Dawes K.E., Kwon O.J., Barnes P.J., Laurent G.J., Chung K.F. Effects of neuropeptides on human lung fibroblast proliferation and chemotaxis. Am. J. Physiol. 268:1995;L278-L283.
23. Joos G., Pauwels R., van der Straeten M. Effect of inhaled substance P and neurokinin A on the airways of normal and asthmatic subjects. Thorax. 42:1987;779-783.
24. Joos G.F., Germonpre P.R., Kips J.C., Peleman R.A., Pauwels R.A. Sensory neuropeptides and the human lower airways: Present state and future directions. Eur. Respir. J. 7:1994;1161-1171.
25. Katsunuma T., Hashimoto K., Akimoto K., Ebisawa M., Iikura Y. Effect of inhaled beclomethasone dipropionate on bronchial responsiveness in patients with asthma. Ann. Allergy. 70:1993;165-170.
26. Lotz M., Vaughan J.H., Carson D.A. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science. 241:1988;1218-1221.
27. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
28. Martling C.R., Theodorsson-Norheim E., Lundberg J.M. Occurence and effects of multiple tachykinins: Substance P, neurokinin A and neuropeptide K in human lower airways. Life Sci. 40:1987;1633-1643.
29. Moguilewsky M., Philibert D. RU 38486: Potent antiglucocorticoid activity correlated with strong binding to the cytosolic glucocorticoid receptor followed by an impaired activation. J. Steroid Biochem. 20:1984;271-276.
30. Munson P.J., Rodbard D. Ligand: A versatile computerized approach for characterization of ligand-binding system. Anal. Biochem. 107:1980;220-239.
31. Nakanishi S., Ohkubo H., Kakizuka A., Yokota Y., Shigemoto R., Sasai Y., Takumi T. Molecular characterization of mammalian tachykinin receptors and a possible epithelial potassium channel. Recent Prog. Horm. Res. 46:1990;59-84.
32. Numao T., Agrawal D.K. Neuropeptides modulate human eosinophil chemotaxis. J. Immunol. 149:1992;3309-3315.
33. Rameshwar P., Gascon P. Induction of negative hematopoietic regulators by neurokinin-A in bone marrow stroma. Blood. 88:1996;98-106.
34. Regoli D., Drapeau G., Dion S., D'Orleans-Juste P. Pharmacological receptors for substance P and neurokinins. Life Sci. 40:1987;109-117.
35. Rodgers J.R., Johnson M.L., Rosen J.M. Measurement of mRNA concentration and mRNA half-life as a function of hormonal treatment. Methods Enzymol. 109:1985;572-592.
36. Sakamoto T., Tsukagoshi H., Barnes P.J., Chung K.F. Involvement of tachykinin receptors (NK1 and NK2) in sodium metabisulfite-induced airway effects. Am. J. Respir. Crit. Care Med. 149:1994;387-391.
37. Sasai Y., Nakanishi S. Molecular characterization of rat substance K receptor and its mRNAs. Bichem. Biophys. Res. Commun. 165:1989;695-702.
38. Sheldrick R.L.G., Rabe K.F., Fischer A., Magnussen H., Coleman R.A. Further evidence that tachykinin-induced contraction of human isolated bronchus is mediated only by NK2-receptor. Neuropeptides. 29:1995;281-292.
39. Solway J., Leff A.R. Sensory neuropeptides and airway function. J. Appl. Physiol. 71:1991;2077-2087.
40. Solway J., Kao B.M., Jordan J.E., Gitter B., Rodger I.W., Howbert J.J., Alger L.E., Necheles J., Leff A.R., Garland A. Tachykinin receptor antagonists inhibit hyperpnea-induced bronchoconstriction in guinea pigs. J. Clin. Invest. 92:1993;315-323.